Sleep-disordered breathing in hypertrophic cardiomyopathy:Challenges and opportunities

Tomas Konecny; Virend K. Somers

doi:10.1378/chest.14-0084

Sleep-disordered breathing in hypertrophic cardiomyopathy:Challenges and opportunities

Tomas Konecny, Virend K. Somers

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Sleep-disordered breathing (SDB) may be a treatable risk factor in patients with hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy. Evidence suggests a high prevalence of SDB in HCM. We summarize the pathophysiology of SDB as it relates to hypertension, coronary artery disease, atrial fi brillation, and sudden cardiac death in patients with HCM. The implications regarding the care of patients with HCM and SDB are discussed as well as the knowledge defi cits needing further exploration.

Original language	English (US)
Pages (from-to)	228-234
Number of pages	7
Journal	Chest
Volume	146
Issue number	1
DOIs	https://doi.org/10.1378/chest.14-0084
State	Published - Jul 2014

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1378/chest.14-0084

Cite this

@article{1a62d5cdb47246f6b6f4eda2769238b8,

title = "Sleep-disordered breathing in hypertrophic cardiomyopathy:Challenges and opportunities",

abstract = "Sleep-disordered breathing (SDB) may be a treatable risk factor in patients with hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy. Evidence suggests a high prevalence of SDB in HCM. We summarize the pathophysiology of SDB as it relates to hypertension, coronary artery disease, atrial fi brillation, and sudden cardiac death in patients with HCM. The implications regarding the care of patients with HCM and SDB are discussed as well as the knowledge defi cits needing further exploration.",

author = "Tomas Konecny and Somers, {Virend K.}",

note = "Funding Information: Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Somers has served as a consultant for Neu Pro; Respircardia, Inc; Sorin Inc; Price Waterhouse; and ResMed and has received grant support from Philips-Respironics Foundation. Dr Konecny has reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. ",

year = "2014",

month = jul,

doi = "10.1378/chest.14-0084",

language = "English (US)",

volume = "146",

pages = "228--234",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "1",

}

TY - JOUR

T1 - Sleep-disordered breathing in hypertrophic cardiomyopathy:Challenges and opportunities

AU - Konecny, Tomas

AU - Somers, Virend K.

N1 - Funding Information: Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Somers has served as a consultant for Neu Pro; Respircardia, Inc; Sorin Inc; Price Waterhouse; and ResMed and has received grant support from Philips-Respironics Foundation. Dr Konecny has reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

PY - 2014/7

Y1 - 2014/7

N2 - Sleep-disordered breathing (SDB) may be a treatable risk factor in patients with hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy. Evidence suggests a high prevalence of SDB in HCM. We summarize the pathophysiology of SDB as it relates to hypertension, coronary artery disease, atrial fi brillation, and sudden cardiac death in patients with HCM. The implications regarding the care of patients with HCM and SDB are discussed as well as the knowledge defi cits needing further exploration.

AB - Sleep-disordered breathing (SDB) may be a treatable risk factor in patients with hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy. Evidence suggests a high prevalence of SDB in HCM. We summarize the pathophysiology of SDB as it relates to hypertension, coronary artery disease, atrial fi brillation, and sudden cardiac death in patients with HCM. The implications regarding the care of patients with HCM and SDB are discussed as well as the knowledge defi cits needing further exploration.

UR - http://www.scopus.com/inward/record.url?scp=84903846741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903846741&partnerID=8YFLogxK

U2 - 10.1378/chest.14-0084

DO - 10.1378/chest.14-0084

M3 - Article

C2 - 25010966

AN - SCOPUS:84903846741

SN - 0012-3692

VL - 146

SP - 228

EP - 234

JO - Chest

JF - Chest

IS - 1

ER -

Sleep-disordered breathing in hypertrophic cardiomyopathy:Challenges and opportunities

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this